Deciphera Pharmaceuticals Inc (DCPH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

200 SMITH STREET WALTHAM, MA 02451

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.

Data as of 2021-04-11 08:00:22 -0400
Market Cap2.525 Billion Shares Outstanding57.626 Million Avg 30-day Volume354.422 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-10.31 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.28272 52-week High/Low68.4 / 39.42 Next Earnings Date2021-05-05 Price to Cash FLow (P/CF) -37.6841
Data provided by IEX Cloud
View SEC Filings from DCPH instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 5 -20.0% 3 (0.18%) 4 (0.25%) -25.0%
Funds Holding: 178 158 12.66% 63 (3.79%) 52 (3.24%) 21.15%
13F shares: 42.986 Million 41.878 Million 2.64% 17.796 Million 18.747 Million -5.07%
% Ownership 75.5025 73.5569 2.65% 31.258 32.928 -5.07%
New Positions: 33 15 120.0% 18 8 125.0%
Increased Positions 69 62 11.29% 15 17 -11.76%
Closed Positions 11 21 -47.62% 6 13 -53.85%
Reduced Positions 49 53 -7.55% 21 18 16.67%
Total Calls 451.396 Thousand 445.3 Thousand 1.37% 292.46 Thousand 224.36 Thousand 30.35%
Total Puts 282.827 Thousand 425.598 Thousand -33.55% 67.9 Thousand 208.072 Thousand -67.37%
PUT/CALL Ratio 0.63 0.96 -34.37% 0.23 0.93 -75.27%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DCPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

31.9 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

30.7 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRISTOL JAMES ARTHUR

  • Director
29,150 2021-04-12 6

TAYLOR MICHAEL DOUGLAS

  • Director
2,354 2021-04-01 13

MARTIN DANIEL C. CHIEF COMMERCIAL OFFICER

  • Officer
27,702 2021-03-23 1

PITMAN JAMA SVP, REGULATORY & QUALITY

  • Officer
16,993 2021-03-23 1

HOERTER STEVEN L. PRESIDENT AND CEO

  • Officer
  • Director
40,695 2021-03-18 8

KELLY THOMAS PATRICK CHIEF FINANCIAL OFFICER

  • Officer
17,616 2021-02-16 4

FLYNN DANIEL LEE CHIEF SCIENTIFIC OFFICER

  • Officer
339,087 2021-02-16 3

SHERMAN MATTHEW L EVP & CHIEF MEDICAL OFFICER

  • Officer
48,386 2021-02-16 4

WALSH DENNIS LEO

  • Director
0 2021-01-15 3

FRIEDMAN FRANKLIN STUART

  • Director
0 2021-01-15 3

SQUARER RON

  • Director
0 2021-01-15 3

KELLEY SUSAN L.

  • Director
0 2020-07-15 2

ALLEN PATRICIA L

  • Director
0 2020-06-10 2

BENZ EDWARD J. JR

  • Director
0 2020-06-10 1

MARTIN JOHN RICHARD

  • Director
0 2020-06-10 1

MORL CHRISTOPHER JOHN CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-15 0

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURES III, L.P.

NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF BPO ASSOCIATES I, L.P.

  • 10% Owner
7,708,280 2019-08-15 0

ROSS MICHAEL JAY

  • Director
0 2019-06-11 0

RUDDY STEPHEN B. CHIEF TECHNICAL OFFICER

  • Officer
0 2019-01-30 0

RATCLIFFE LIAM

  • Director
  • 10% Owner
0 2018-05-17 0

BRIGHTSTAR ASSOCIATES LLC

  • 10% Owner
16,572,370 2017-10-02 0

ROSEN OLIVER CHIEF MEDICAL OFFICER

  • Officer
0 2017-10-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BRISTOL JAMES ARTHUR - Director

2021-04-14 16:00:20 -0400 2021-04-12 S 5,217 $44.09 d 0 direct yes

BRISTOL JAMES ARTHUR - Director

2021-04-14 16:00:20 -0400 2021-04-12 S 9,483 $43.70 d 5,217 direct yes

BRISTOL JAMES ARTHUR - Director

2021-04-14 16:00:20 -0400 2021-04-12 M 14,700 d 29,150 direct

BRISTOL JAMES ARTHUR - Director

2021-04-14 16:00:20 -0400 2021-04-12 M 14,700 $3.95 a 14,700 direct

TAYLOR MICHAEL DOUGLAS - Director

2021-04-06 06:00:31 -0400 2021-04-01 M 8,000 d 2,354 direct

TAYLOR MICHAEL DOUGLAS - Director

2021-04-06 06:00:31 -0400 2021-04-01 S 2,100 $44.80 d 5,900 direct yes -1.7757 -2.3601 0.0 1 -2.3601 6

TAYLOR MICHAEL DOUGLAS - Director

2021-04-06 06:00:31 -0400 2021-04-01 S 906 $46.72 d 0 direct yes -1.7757 -2.3601 0.0 1 -2.3601 6

TAYLOR MICHAEL DOUGLAS - Director

2021-04-06 06:00:31 -0400 2021-04-01 M 8,000 $1.89 a 8,000 direct -1.7757 -2.3601 0.0 1 -2.3601 6

TAYLOR MICHAEL DOUGLAS - Director

2021-04-06 06:00:31 -0400 2021-04-01 S 4,994 $45.69 d 906 direct yes -1.7757 -2.3601 0.0 1 -2.3601 6

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2021-03-22 17:00:12 -0400 2021-03-18 F 700 $42.39 d 43,145 direct yes -1.4456 -4.704 0.4589 4 -7.2969 5

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2021-03-22 17:00:12 -0400 2021-03-18 F 2,450 $43.19 d 40,695 direct yes -1.4456 -4.704 0.4589 4 -7.2969 5

TAYLOR MICHAEL DOUGLAS - Director

2021-03-03 16:00:52 -0500 2021-03-01 S 6,896 $43.94 d 1,104 direct yes -0.3957 1.1755 1.1755 6 -5.9823 3

TAYLOR MICHAEL DOUGLAS - Director

2021-03-03 16:00:52 -0500 2021-03-01 M 8,000 d 10,354 direct

TAYLOR MICHAEL DOUGLAS - Director

2021-03-03 16:00:52 -0500 2021-03-01 M 8,000 $1.89 a 8,000 direct -0.3957 1.1755 1.1755 6 -5.9823 3

TAYLOR MICHAEL DOUGLAS - Director

2021-03-03 16:00:52 -0500 2021-03-01 S 1,104 $44.68 d 0 direct yes -0.3957 1.1755 1.1755 6 -5.9823 3

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2021-02-18 18:08:19 -0500 2021-02-16 A 210,000 d 210,000 direct

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2021-02-18 19:00:23 -0500 2021-02-16 A 11,100 a 17,632 direct -2.0468 -1.5295 3.5538 3.9361 21 -9.1543 12

SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER

2021-02-18 19:00:16 -0500 2021-02-16 A 11,100 a 48,386 direct -2.0468 -1.5295 3.5538 3.9361 21 -9.1543 12

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2021-02-18 19:00:25 -0500 2021-02-16 A 11,100 a 17,616 direct -2.0468 -1.5295 3.5538 3.9361 21 -9.1543 12

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2021-02-18 19:00:23 -0500 2021-02-16 S 508 $48.87 d 6,532 direct -2.0468 -1.5295 3.5538 3.9361 21 -9.1543 12

SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER

2021-02-18 19:00:16 -0500 2021-02-16 S 132 $48.87 d 37,286 direct -2.0468 -1.5295 3.5538 3.9361 21 -9.1543 12

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2021-02-18 19:00:25 -0500 2021-02-16 S 524 $48.87 d 6,516 direct -2.0468 -1.5295 3.5538 3.9361 21 -9.1543 12

FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER

2021-02-18 19:00:23 -0500 2021-02-16 A 49,900 a 49,900 direct

SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER

2021-02-18 19:00:16 -0500 2021-02-16 A 49,900 a 49,900 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2021-02-18 19:00:25 -0500 2021-02-16 A 49,900 a 49,900 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 22:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 21:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 21:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 20:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 20:15:04 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 19:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 19:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 18:45:02 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 18:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 17:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 17:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 16:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 16:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 15:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 15:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 14:45:02 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 14:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 13:45:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 13:15:03 UTC -0.359 0.419 400000
DECIPHERA PHARMACEUTICALS IN DCPH 2021-04-14 12:45:03 UTC -0.359 0.419 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Long/Short Equity Fund DCPH -424.0 shares, $-26203.2 2020-11-30 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund DCPH -1514.0 shares, $-68145.14 2020-08-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund DCPH -126.0 shares, $-5187.42 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund DCPH -49.0 shares, $-2017.33 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund DCPH -18.0 shares, $-923.4 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund DCPH -106.0 shares, $-4364.02 2020-03-31 N-PORT

Elevate your investments